Bristol-Myers Squibb (BMY) Declares $0.45 Quarterly Dividend; 3.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Bristol-Myers Squibb (BMY) Confirms JCAR017 Plants Have Been Inspected by FDA - Bloomberg
September 8, 2020 3:43 PM EDTBristol-Myers Squibb (NYSE: BMY) Confirms JCAR017 Plants Have Been Inspected by FDA - Bloomberg
Bristol-Myers Squibb CVR Sinks on FDA Manufacturing Plant Inspections - Mizuho
September 8, 2020 1:17 PM EDTBristol-Myers Squibb CVR (NYSE: BMY-R) is trading down 20%. Mizuho analyst Salim Syed highlighted that management disclosed the FDA has communicated to BMY that both the JCAR017 manufacturing facility in Bothell, WA and vector CMO facility in Texas will require inspection.
The analyst... More
Bristol-Myers Squibb (BMY) Research at ESMO Virtual Congress 2020 Highlights Significant Progress in Cancers with High Unmet Medical Need
September 8, 2020 7:00 AM EDTBristol Myers Squibb (NYSE: BMY) today announced the presentation of research spanning 15 different cancers at the upcoming European Society for Medical Oncology (ESMO) Virtual Congress 2020, reinforcing the depth and breadth of its oncology development program, leadership in immuno-oncology and commitment to delivering value to patients and health systems by discovering potential options to improve long-term outcomes in... More



